Anti-Estrogen Steroids Faslodex Hormonal Faslodex 129453-61-8 For Cancer Treatment

Anti-Estrogen Steroids Faslodex Hormonal Faslodex 129453-61-8 For Cancer Treatment 

1. Quick Detail: 

Alias: Faslodex AstraZeneca 

CAS Registry Number: 129453-61-8 

Assay: 97.0%~103.0% 

Molecular Fomular: C32H47F5O3S 

Molecular Weight: 606.77 

Density: 1.201 g/cm3 

Melting Point: 104-106º C 

Appearance: White powder 

Grade: Pharmaceutical Grade 

Storage: Shading, confined preservation 

Manufacturer: GONGCHUANG 

Delivery: EMS, DHL, TNT, FedEx, UPS 

2. Applications: 

In particular 4 clinical trials in this setting did show similar efficacy to the other hormonal agents (aromatase inhibitors and tamoxifen) with good tolerability profile. Fulvestrant had a lower incidence of joint disorders. 

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.